314 related articles for article (PubMed ID: 16419003)
1. [SLE: Extra-renal clinical manifestations and lupus nephritis].
Gallelli B; De Angelis V; Ventura D; Meroni PL; Moroni G
G Ital Nefrol; 2005; 22 Suppl 33():S3-10. PubMed ID: 16419003
[TBL] [Abstract][Full Text] [Related]
2. [The characteristics of kidney involvement in a female patient with systemic lupus erythematosus and the antiphospholipid syndrome].
Kozlovskaia NL; Kabaenkova GS; Varshavskiĭ VA; Shvetsov MIu
Klin Med (Mosk); 1995; 73(3):93-6. PubMed ID: 8577127
[TBL] [Abstract][Full Text] [Related]
3. Review: Lupus nephritis: pathologic features, epidemiology and a guide to therapeutic decisions.
Ortega LM; Schultz DR; Lenz O; Pardo V; Contreras GN
Lupus; 2010 Apr; 19(5):557-74. PubMed ID: 20089610
[TBL] [Abstract][Full Text] [Related]
4. Silent renal disease in systemic lupus erythematosus.
Font J; Torras A; Cervera R; Darnell A; Revert L; Ingelmo M
Clin Nephrol; 1987 Jun; 27(6):283-8. PubMed ID: 3497000
[TBL] [Abstract][Full Text] [Related]
5. The clinical and renal biopsy predictors of long-term outcome in lupus nephritis: a study of 87 patients and review of the literature.
Esdaile JM; Levinton C; Federgreen W; Hayslett JP; Kashgarian M
Q J Med; 1989 Sep; 72(269):779-833. PubMed ID: 2694209
[TBL] [Abstract][Full Text] [Related]
6. Elevated serum anti-endothelial cell autoantibodies titer is associated with lupus nephritis in patients with systemic lupus erythematosus.
Tseng JC; Lu LY; Hu RJ; Kau CK; Cheng HH; Lin PR; Sun CW; Liang HT; Lam HC; Tai MH
J Microbiol Immunol Infect; 2007 Feb; 40(1):50-5. PubMed ID: 17332907
[TBL] [Abstract][Full Text] [Related]
7. Renal vascular lesions in systemic lupus erythematosus.
Katz SM; Korn S; Umlas SL; DeHoratius RJ
Ann Clin Lab Sci; 1990; 20(2):147-53. PubMed ID: 2327730
[TBL] [Abstract][Full Text] [Related]
8. Prevalence and clinicopathologic findings of antiphospholipid syndrome nephropathy in Thai systemic lupus erythematosus patients who underwent renal biopsies.
Cheunsuchon B; Rungkaew P; Chawanasuntorapoj R; Pattaragarn A; Parichatikanond P
Nephrology (Carlton); 2007 Oct; 12(5):474-80. PubMed ID: 17803471
[TBL] [Abstract][Full Text] [Related]
9. Serial renal biopsy in systemic lupus erythematosus.
Bajaj S; Albert L; Gladman DD; Urowitz MB; Hallett DC; Ritchie S
J Rheumatol; 2000 Dec; 27(12):2822-6. PubMed ID: 11128670
[TBL] [Abstract][Full Text] [Related]
10. Renal disease in systemic lupus erythematosus.
Balow JE; Austin HA
Rheum Dis Clin North Am; 1988 Apr; 14(1):117-33. PubMed ID: 3041484
[TBL] [Abstract][Full Text] [Related]
11. Adrenomedullin--a potential disease activity marker and suppressor of nephritis activity in systemic lupus erythematosus.
Mak A; Cheung BM; Mok CC; Leung R; Lau CS
Rheumatology (Oxford); 2006 Oct; 45(10):1266-72. PubMed ID: 16595522
[TBL] [Abstract][Full Text] [Related]
12. Clinical usefulness of the morphological classification of lupus nephritis.
Baldwin DS
Am J Kidney Dis; 1982 Jul; 2(1 Suppl 1):142-9. PubMed ID: 7102664
[TBL] [Abstract][Full Text] [Related]
13. Oral manifestation of systemic lupus erythematosus: lupus nephritis--report of a case.
Sverzut AT; Allais M; Mazzonetto R; de Moraes M; Passeri LA; Moreira RW
Gen Dent; 2008; 56(1):35-41. PubMed ID: 18254558
[TBL] [Abstract][Full Text] [Related]
14. Correlation of clinical and pathological findings in patients with lupus nephritis: a five-year experience in Iran.
Nezhad ST; Sepaskhah R
Saudi J Kidney Dis Transpl; 2008 Jan; 19(1):32-40. PubMed ID: 18087120
[TBL] [Abstract][Full Text] [Related]
15. Disease activity, damage and survival in Mexican patients with acute severe systemic lupus erythematosus.
Zonana-Nacach A; Yañez P; Jiménez-Balderas FJ; Camargo-Coronel A
Lupus; 2007; 16(12):997-1000. PubMed ID: 18042596
[TBL] [Abstract][Full Text] [Related]
16. Posterior reversible encephalopathy syndrome--an underrecognized manifestation of systemic lupus erythematosus.
Kur JK; Esdaile JM
J Rheumatol; 2006 Nov; 33(11):2178-83. PubMed ID: 16960925
[TBL] [Abstract][Full Text] [Related]
17. Predominance of CD8+ T lymphocytes among periglomerular infiltrating cells and link to the prognosis of class III and class IV lupus nephritis.
Couzi L; Merville P; Deminière C; Moreau JF; Combe C; Pellegrin JL; Viallard JF; Blanco P
Arthritis Rheum; 2007 Jul; 56(7):2362-70. PubMed ID: 17599764
[TBL] [Abstract][Full Text] [Related]
18. Lupus nephritis.
Sauter M; Anders HJ
Minerva Med; 2007 Dec; 98(6):749-58. PubMed ID: 18299686
[TBL] [Abstract][Full Text] [Related]
19. Factors associated with refractory renal disease in patients with systemic lupus erythematosus: the role of patient nonadherence.
Bruce IN; Gladman DD; Urowitz MB
Arthritis Care Res; 2000 Dec; 13(6):406-8. PubMed ID: 14635317
[TBL] [Abstract][Full Text] [Related]
20. Role of lipids in the progression of renal disease in systemic lupus erythematosus patients.
Luzar B; Ferluga D
Wien Klin Wochenschr; 2000 Aug; 112(15-16):716-21. PubMed ID: 11020963
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
